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CLC-5 plays a critical role in the process of endocytosis in the proximal tubule of the
kidney and mutations that alter protein function are the cause of Dent’s I disease. In this
X-linked disorder impaired reabsorption results in the wasting of calcium and lowmolecular
weight protein to the urine, kidney stones, and progressive renal failure. Several different
ion-transporting and protein clustering roles have been proposed as the physiological
function of CLC-5 in endosomal membranes. At the time of its discovery, nearly 20 years
ago, it was understandably assumed to be a chloride channel similar to known members
of the CLC family, such as CLC-1, suggesting that chloride transport by CLC-5 was critical
for endosomal function. Since then CLC-5 was found instead to be a 2Cl−/H+ exchange
transporter with voltage-dependent activity. Recent studies have determined that it is this
coupled exchange of protons for chloride, and not just chloride transport, which is critical
for endosomal and kidney function. This review discusses the recent ideas that describe
how CLC-5 might function in endosomal membranes, the aspects that we still do not
understand, and where controversies remain.
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INTRODUCTION
Like several other proteins that mediate the movement of Cl−
ions across membranes, CLC-5 was identified as a protein defec-
tive in human disease. In this case, the search for genes underlying
Dent’s disease, an inherited kidney disorder, identified the CLCN5
gene and sequence variations in Dent’s patients (Fisher et al.,
1995; Lloyd et al., 1996). In this X-linked disorder, individuals
have severely reduced kidney function with defective reabsorp-
tion of lowmolecular weight protein (e.g., albumin, hormone and
vitamin binding proteins, microgobulins) and Ca2+ by the renal
tubules, which appear at unusually high levels in urine. Kidney
stones are frequently observed in Dent’s patients, occasionally
rickets, and the disorder often progresses to complete renal fail-
ure. Many different mutations have been identified, including
nonsense, missense, and mis-splicing, and which affect protein
function, processing, or trafficking (Grand et al., 2009; Smith
et al., 2009; Lourdel et al., 2012).
CLC-5 is a member of the CLC family of Cl− channels
and 2Cl−/H+ transporters, still known today as the voltage-
gated chloride channel family, and have 9 human members.
This classification was based on the functional properties of
CLC-1, a plasma membrane Cl− channel that is involved in
skeletal muscle excitability. CLC-1 exhibits outward rectification
through increased open probability when the membrane becomes
depolarized (Jentsch et al., 1995). These properties, however,
proved to be the exception rather than the defining character-
istics of the whole protein family: CLC-2 is inwardly-rectifying,
CLC-Ka and Kb exhibit little voltage-dependence and generally
form a Cl− leak conductance, whilst the other members CLC–3
to 7 have more recently been shown to function as outwardly-
rectifying 2Cl−/H+-exchange transporters (Picollo and Pusch,
2005; Scheel et al., 2005; Neagoe et al., 2010; Leisle et al., 2011)
and are predominantly located in the membranes of intracellu-
lar organelles, particularly endosomes, lysosomes, and exocytic
vesicles.
Early studies led to the proposal that CLC-5 played a sup-
porting role to H+-ATPase, which actively pumps H+ into
endosomes, by providing a Cl−-permeable shunt conductance.
This process maintains endosomal acidification because passive
entry of Cl− into endosomes, flowing down an electrochemi-
cal gradient, can dissipate the build-up of positive charge in the
endosome by the accumulated H+. Because the affected gene
was identified as a member of the CLCN gene family (Koch
et al., 1992) the supposition that CLC-5 was also a Cl− chan-
nel would have been both logical and uncontroversial. Secondly,
immunohistochemical studies with CLC-5 antisera pinpointed
CLC-5 to subapical endosomes in proximal tubule epithelia, colo-
calizing with H+-ATPase (Gunther et al., 1998). These ideas
were supported by studies on mice lacking CLC-5, which exhibit
several of the features characteristic of Dent’s disease, where
loss of CLC-5 was linked to defective endosomal acidification
and receptor-mediated endocytosis (Piwon et al., 2000; Wang
et al., 2000; Silva et al., 2003). Acidification is important because
it promotes the dissociation of endocytosed protein from the
receptor, megalin and cubulin (Christensen et al., 2009), and
allows the recycling of the receptor back to the apical mem-
brane for further endocytosis. It is also important for the pro-
cess of endosomal maturation and enzyme activation along the
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endosomal-lysosomal pathway. Defective endocytosis through
altered endosomal function thus explains the low molecular
weight proteinuria that is the hallmark of Dent’s disease and its
downstream effects.
Is 2Cl−/H+ transport by CLC-5 compatible with an electrical
shunt or does this transporter contribute to cellular physiol-
ogy in another way? Since the exchange stoichiometry involves
one H+ exchanged for two Cl−, each cycle would neutralise
the charge of three H+ pumped in by the ATPase, but at the
cost of one H+ transported out by CLC-5. Surely nature would
have evolved a more efficient process by making use of any
of the available Cl−-selective ion channels or does CLC-5 do
something unique? In this mini-review we discuss the chang-
ing ideas of the role of CLC-5 in endosomal physiology and
its pathophysiology in Dent’s disease. Certainly, CLC-5 remains
a major contributor to endosomal function, but studies that
interrogate the precise role provide confusing and conflicting
conclusions. The reader is also referred to other recent reviews
in the field that explore this area and other more comprehen-
sive aspects of intracellular CLC and organelle function (Plans
et al., 2009; Wellhauser et al., 2010; Scott and Gruenberg,
2011).
NON-TRANSPORTING PROPERTIES OF CLC-5
Before considering the ion transport activity of CLC-5 we first
ask if this is its only role or even if it is important at all.
Electrophysiological studies show that depolarization to mem-
brane potentials more positive to 0mV are required to activate
CLC-5 (Friedrich et al., 1999; Smith and Lippiat, 2010a). Surface-
expressed transporters would rarely experience these potentials
if at all under normal conditions and so transport-related activ-
ity at the plasma membrane would be unlikely. Furthermore, we
do not understand how the potential across endosomal mem-
branes might be regulated. Aside from this, changes in the
distribution and trafficking of other plasma membrane pro-
teins that are important to the process of endocytosis have
been reported in proximal tubule cells; these include H+-ATPase
(Moulin et al., 2003), megalin and cubulin (Christensen et al.,
2003), and the NHE3 Na+/H+ exchanger (Lin et al., 2011).
The trafficking and colocalization with CLC-5 may be due to
protein-protein interactions in either surface or endosomal mem-
branes, which would be lost when CLC-5 is absent or deficient.
For example NHE3 has been shown to cluster with CLC-5
via the NHERF3 scaffolding protein (Hryciw et al., 2012). An
alternative explanation for altered trafficking of membrane pro-
teins could be as an effect secondary to impaired organelle
acidification.
The CLC-5 intracellular domains contain a PY motif, which
can interact with E3 ubiquitin ligases. Ubiquitinylation might
mark CLC-5 for internalization by endocytosis, resulting in vesi-
cle formation, or target intracellular CLC-5 directly to endo-
somes rather than the plasma membrane (Schwake et al., 2001;
Hryciw et al., 2004). Consistent with this, co-expression of ubiq-
uitin ligases reduced the surface density of CLC-5, whereas it
was increased by mutation of the PY motif (Schwake et al.,
2001; Hryciw et al., 2004). However, transgenic mice express-
ing CLC-5 with the same mutation that disrupted the PY motif
appear normal and do not have defective endocytosis (Rickheit
et al., 2010). This was a somewhat surprising finding and sug-
gests that this manner of regulation by protein interaction and
post-translational modification is not crucial for endocytosis.
Ubiquitinylation of CLC-5 may promote lysosomal degradation
of the protein, and so a decrease in degradation might explain
the increase in CLC-5 at the cell surface through reduced recy-
cling. Another interaction, involving the C-terminal domains
of CLC-5 with KIF3B, part of the kinesin motor complex, is
important for the transport of CLC-5-containing vesicles along
microtubules away from the apical membrane (Reed et al., 2009).
This process may also involve the actin-binding and remod-
eling enzyme cofilin, which also interacts with the intracellu-
lar domains of CLC-5 and regulates albumin uptake (Hryciw
et al., 2003). Disease-causing mutations that alter the sub-
cellular expression of CLC-5 (Smith et al., 2009) or disrupt
C-terminal interaction domains may, therefore, affect the pro-
cess of vesicular transport and contribute to the pathophysiol-
ogy of Dent’s disease (Reed et al., 2009). Overall, these studies
suggest that irrespective of ion transport activity the presence
of particular CLC-5 protein domains is likely to be important
and contribute to the cellular biology. Expression of transport-
deficient CLC-5 protein could be employed to investigate this
further.
IS CLC-5 ACTIVE IN ENDOSOMES?
The major problem in defining a physiological role for CLC-5
in its native environment is that it exerts its influence and
putative ion-transporting abilities within the confines of subcel-
lular endocytic vesicles. Unlike the study of ion channels and
transporters at the cell surface, these membranes are gener-
ally inaccessible to patch clamp micropipettes and the ability
to define the ionic environment. It has not been possible to
determine CLC-5 activity directly and the direction of ion flux
through the active transporter in either isolated endosomes or
in the intact cell. Fluorescent indicators have been loaded or
targeted to endosomes that report changes in luminal pH or
[Cl−] (Gunther et al., 2003; Hara-Chikuma et al., 2005; Smith
and Lippiat, 2010a). These experiments are unable to iden-
tify precisely the routes taken by H+ and Cl− between cyto-
plasm and endosome, but inhibition of H+-ATPase (e.g., by
bafilomycin-A1) or Cl− channels (e.g., by NPPB) have been used
to establish their relative contribution. Much of our understand-
ing of CLC-5 function has come from overexpression studies
and the properties of a minority population that resides in
the plasma membrane. Electrophysiological studies show that
overexpressed wild-type CLC-5 at the plasma membrane can
only transport ions when depolarized to positive membrane
potentials. At present, we do not know if voltage-dependent
2Cl−/H+ transport by CLC-5 is maintained in endosomal
membranes or if a different behavior exists. If the biophysical
properties are consistent then the cytoplasm must be more pos-
itive to an endosomal-negative potential (equivalent to depo-
larization) for activity to occur. In this case, electrogenic H+
pumping into the endosome by H+-ATPase would generate
an endosomal positive potential which would render CLC-5
inactive.
Frontiers in Physiology | Membrane Physiology and Biophysics November 2012 | Volume 3 | Article 449 | 2
Lippiat and Smith Physiology and pathophysiology of CLC-5
Pharmacological tools that enable the selective and acute inhi-
bition of CLC-5 are absent. Unlike many Cl− channels and
transporters, CLC-5 is insensitive to the commonly-used non-
selective inhibitors such as NPPB, DIDS, and niflumic acid
(Steinmeyer et al., 1995; Mo et al., 1999). These drugs have been
used to provide evidence for involvement of Cl− channels in
receptor-mediated endocytosis or endosomal acidification, but
in such studies CLC-5 must be discounted as the drug-sensitive
Cl− pathway and a different drug-sensitive channel or trans-
porter protein must be present in proximal tubule endosomes
(Hara-Chikuma et al., 2005).
CLC-5 function in endosomes has, therefore, been studied
by comparing cellular function between cells that have and
those that lack functional CLC-5. Endosomal accumulation of
both H+ (acidification) and Cl− is reduced in proximal tubule
cells from CLC-5 knockout mice (Hara-Chikuma et al., 2005).
Findings such as this could be explained by different underlying
mechanisms: a defect in H+ transporting protein, a Cl− con-
ductance, or a loss of a scaffolding protein that clusters H+ and
Cl− transporters/channels to the same endosomal membrane.
A reduction in endosomal acidification or [Cl−] could be the
result of either the loss of a Cl− conductance, which reduces
acidification, or of defective H+ transport, which would reduce
the amount Cl− required to enter the endosome to dissipate
charge.
From the studies discussed so far it can be concluded that the
presence of CLC-5 is important for endocytosis and is associated
with changes in endosomal pH and [Cl−]. What had yet to be
identified, however, is at what point in the process of endocytosis
is CLC-5 active and whether it is the transport of Cl−, H+, or both
that is critical.
2CL−/H+ EXCHANGE IS CRITICAL TO ENDOSOMAL
ACIDIFICATION AND KIDNEY FUNCTION
Two studies addressed the issue of ion exchange by studying
the physiology of mutant CLC-5 expressed either as a trans-
gene in mice (Novarino et al., 2010) or studied in cultured
cells (Smith and Lippiat, 2010a). The E211A mutation converts
CLC-5 from an outwardly rectifying 2Cl−/1H+ exchange trans-
porter into a non-rectifying Cl− conductance by uncoupling the
H+ transport, and thereby forms a passive Cl− conductance
(Picollo and Pusch, 2005; Scheel et al., 2005). Mice expressing
E211A CLC-5 exhibit proteinuria, similar to CLC-5 knockout
mice, but ATP-dependent endosomal acidification appeared nor-
mal (Novarino et al., 2010). Novarino et al. (2010) hypothesized
that endosomal Cl− accumulation via CLC-5 and driven by the
endosome-cytosolic pH gradient is critical for endocytosis. This
would imply that Cl− flowing into endosomes down its elec-
trochemical gradient is insufficient for endosomal function and
requires CLC-5 to transport additional Cl− into endosomes in
exchange for H+. This direction of ion flux through CLC-5
has yet to be observed (Figure 1) and therefore requires CLC-5
to function in novel way. Electrophysiological studies demon-
strate that CLC-5 only transports ions in the opposite direc-
tion to this: only outward currents have been observed from
cells overexpressing CLC-5, which correspond to transport of
FIGURE 1 | Biophysical properties suggest transport of H+ into
endosomes by CLC-5. (A) A family of CLC-5 currents recorded from a
transfected HEK293 cell by the whole-cell patch-clamp technique. The
dotted line represents the zero current baseline. Pulses were applied
from −100 to +100mV as illustrated by the voltage protocol. Only outward
currents (upward currents from the baseline), corresponding to H+ efflux
and Cl− influx, are observed with CLC-5 expressed at the cell surface,
indicated by the arrows to the right of the currents. Ion flux in the opposite
direction would be recorded as inward currents (downward deflection from
baseline) and these were not observed under all [Cl−] and pH conditions
tested (Smith and Lippiat, 2010a). The transient inward currents upon
repolarization are gating currents and do not involve ion transport across the
membrane (Smith and Lippiat, 2010b). (B) If this property persists in
endosomal membranes then a Cl− gradient, which may occur immediately
upon endocytic vesicle formation, may drive the transport of H+ into
endosomes by CLC-5. It is assumed that the arrangement of
transmembrane and intracellular domains of CLC-5 are consistent between
plasma and endosomal membranes, as indicated by the representation
of the crystal structure of a homologous eukaryotic CLC transporter
(Feng et al., 2010). Ion transport through one subunit of the dimer is
indicated by the arrows and the proteins and could provides the
H+-ATPase-independent acidification component identified by (Smith and
Lippiat, 2010a). Other transporters and membrane proteins that colocalize
with CLC-5 are omitted from this cartoon.
H+ from and Cl− into the cytoplasm (Figure 1). One must
also consider that in order to transport enough Cl− ions to
change endosomal [Cl−] even by a few millimolar, a similar
amount of H+ must leave the endosome. This might place a
considerable energetic strain on endosomal H+-ATPase, which
is likely to have a turnover rate at least an order of magni-
tude lower than that of a typical CLC transporter (Jayaram
et al., 2008), and the latter could readily deplete endosomal
H+ by functioning in this way. In any case, measurements of
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endosomal pH reveal that the presence of CLC-5 results in
a lower pH, which is inconsistent with it providing a means
for H+ to leave endosomes (Hara-Chikuma et al., 2005; Smith
and Lippiat, 2010a) and any passive Cl− conductance in endo-
somal membranes may make it difficult to maintain high
endosomal [Cl−].
In agreement that 2Cl−/H+ exchange was the critical pro-
cess we showed, using a targeted pH indicator, that wild-type
CLC-5 could enhance endosomal acidification when overex-
pressed in HEK293 cells, but this effect was not reproduced
by expressing either the uncoupled Cl−-transporting mutant
(E211A) nor by a transport-null mutant (E268A) (Smith and
Lippiat, 2010a). Since the electrophysiological properties of CLC-
5 suggested that it could only transport H+ from and not into
the cytoplasm (Figure 1) the study inferred that CLC-5 pro-
vided a mechanism for endosomal acidification distinct from
the active pumping by H+-ATPase. This idea was supported by
identifying the bafilomycin-sensitive (H+-ATPase) and insensi-
tive (CLC-5) acidification components in both the recombinant
expression system and in cultured proximal tubule cells (Smith
and Lippiat, 2010a). This process restricts the contribution of
CLC-5 to endosomal acidification when there is sufficient endo-
somal [Cl−] and when there is an endosomal-negative trans-
membrane potential. This may only occur immediately upon
vesicle formation with high [Cl−] in the internalized fluid and
an interior membrane surface charge, extruding Cl− into the
cytoplasm during the first min (Sonawane and Verkman, 2003),
which might involve 2Cl−/H+-exchange by CLC-5 in addi-
tion to any contribution from other transporters and channels.
This would rapidly acidify CLC-5-containing vesicles immedi-
ately upon formation and support constitutive endocytosis by
proximal tubule epithelia. The passive Cl− conductance that is
important for maintaining electroneutrality during H+-ATPase
activity could be provided by the NPPB-sensitive Cl− con-
ductance (Hara-Chikuma et al., 2005) and may involve CFTR,
which is found in endosomal membranes in proximal tubule
epithelia (Jouret et al., 2007). Other Cl−-permeable channels
that have detectable endosomal localization in proximal tubule
cells are CLIC1 (Ulmasov et al., 2007) and AQP6 (Yasui et al.,
1999a,b).
The two distinct mechanisms described here are not
mutually-exclusive, and might describe CLC-5 function at dif-
ferent stages of the process of endocytosis (Novarino et al.,
2010) when ionic gradients and maybe the voltage across
the endosomal membrane change. The biophysical proper-
ties of CLC-5 may be altered by organelle-specific phos-
pholipid content that exists in early and late endosomes
(Falkenburger et al., 2010), or as a result of a yet unidentified
modification.
SUMMARY AND PROSPECTIVE
Defective endocytosis occurs when CLC-5 function is impaired,
either in Dent’s patients with CLCN5 mutations, or in mouse
models with altered or lacking Clcn5 gene. In addition, mutant
CLC-5 that can only conduct Cl−, and not H+, across endoso-
mal membranes cannot support endosomal function (Novarino
et al., 2010; Smith and Lippiat, 2010a). The importance of H+
transport must, therefore, be the key to understanding CLC-5
and the idea that it provides a means to provide Cl− to electri-
cally shunt endosomal H+ accumulation is redundant. Questions
remain as to when during endocytosis and endosomal acidifica-
tion CLC-5 is active and the direction of Cl− and H+ fluxes. Any
method that enables the manipulation of endosomal membrane
potential and ionic content is likely to help dissect out these
processes. As discussed here, the importance of coupled transport
by CLC-5 and the redundancy of the PY motif have been deter-
mined by studying mutant transporters. Identification of other
mutations that alter just one process, e.g., voltage-dependence
or exchange stoichiometry, and studying their effects at the cel-
lular and whole-animal levels may prove to be useful in the
future.
Knowledge of the full endosomal membrane proteome should
also provide insights into endosomal ionic regulation since trans-
porters and channels often work in conjunction to provide con-
stitutive activity. It is unlikely that CLC-5, H+-ATPase, and NHE3
exist in isolation as ion-transporting proteins in endosomalmem-
branes in the proximal tubule. In addition to anion channels,
evidence for the endosomal function of cation-selective chan-
nels from the mucolipin (TRPML) and two pore channel (TPC)
families is emerging (Grimm et al., 2012). Release of calcium
from the newly-formed endocytic vesicle through mucolipin-3
(TRPML3) channels is required for endosomal acidification in
retinal epithelial cells (Lelouvier and Puertollano, 2011). TPC
proteins expressed in endosomal and lysosomal membranes give
rise to a largely Na+-selective channel which, upon activation by
phosphatidylinositol 3,5-bisphosphate, allows Na+ to leave the
lumen (Wang et al., 2012). Release of cations from endosomes
might actually depolarize the endosomal membrane (Wang et al.,
2012), which would favor andmaintain CLC-5 activation. Further
investigation is required in order to establish whether either
cation channel type is expressed and colocalized with CLC-5 in
proximal tubule cells.
Studying ion homeostasis and transport in organelles is a
challenge and requires development of selective and targeted
fluorescent indicators or the means to interrogate ion channel
and transporter function in situ. Imaging and optogenetics may
thus provide tools to enable experiments on intact cells and
organelles. Organelle electrophysiology where endosomal mem-
brane potential and ionic content could be controlled is tech-
nically demanding and is limited by their small size, although
studies on artificially-enlarged endosomes or endolysosomes have
been successfully implemented (Saito et al., 2007; Wang et al.,
2012). CLC-5 is critical for endocytosis and endosomal function
in proximal tubule epithelia. Until we are able to resolve its behav-
ior in more detail, we must suffice ourselves with the conclusion
that it is because of a unique property not shared with any other
class of Cl−-transporting protein found in the kidney, 2Cl−/H+
exchange.
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